80 related articles for article (PubMed ID: 32827681)
1. rs2274911 polymorphism in GPRC6A associated with serum E2 and PSA in a Southern Chinese male population.
Qi N; Chen Y; Zeng Y; Bao M; Long X; Guo Y; Tan A; Gao Y; Zhang H; Yang X; Hu Y; Mo Z; Jiang Y
Gene; 2020 Dec; 763():145067. PubMed ID: 32827681
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism rs2274911 of GPRC6A as a Novel Risk Factor for Testis Failure.
De Toni L; Di Nisio A; Speltra E; Rocca MS; Ghezzi M; Zuccarello D; Turiaco N; Ferlin A; Foresta C
J Clin Endocrinol Metab; 2016 Mar; 101(3):953-61. PubMed ID: 26735260
[TBL] [Abstract][Full Text] [Related]
3. The rs2274911 polymorphism in GPRC6A gene is associated with insulin resistance in normal weight and obese subjects.
Di Nisio A; Rocca MS; Fadini GP; De Toni L; Marcuzzo G; Marescotti MC; Sanna M; Plebani M; Vettor R; Avogaro A; Foresta C
Clin Endocrinol (Oxf); 2017 Feb; 86(2):185-191. PubMed ID: 27696500
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
[TBL] [Abstract][Full Text] [Related]
5. Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.
Ye R; Pi M; Nooh MM; Bahout SW; Quarles LD
Mol Pharmacol; 2019 May; 95(5):563-572. PubMed ID: 30894404
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of GPRC6A in prostate cancer metastasis based on case-control and in vitro analyses.
Liu M; Zhao YY; Yang F; Wang JY; Shi XH; Zhu XQ; Xu Y; Wei D; Sun L; Zhang YG; Yang K; Qu YC; Wang X; Liang SY; Chen X; Zhao CX; Zhu L; Tang L; Zheng CG; Yang Z
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2235-48. PubMed ID: 27338047
[TBL] [Abstract][Full Text] [Related]
7. GPRC6A regulates prostate cancer progression.
Pi M; Quarles LD
Prostate; 2012 Mar; 72(4):399-409. PubMed ID: 21681779
[TBL] [Abstract][Full Text] [Related]
8. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
9. RS 2247911 polymorphism of GPRC6A gene and serum undercarboxylated-osteocalcin are associated with testis function.
Jawich K; Rocca MS; Al Fahoum S; Alhalabi M; Di Nisio A; Foresta C; Ferlin A; De Toni L
J Endocrinol Invest; 2022 Sep; 45(9):1673-1682. PubMed ID: 35482214
[TBL] [Abstract][Full Text] [Related]
10. GPCR6A Is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea.
Pi M; Kapoor K; Ye R; Smith JC; Baudry J; Quarles LD
Mol Nutr Food Res; 2018 Apr; 62(8):e1700770. PubMed ID: 29468843
[TBL] [Abstract][Full Text] [Related]
11. GPRC6A mediates the non-genomic effects of steroids.
Pi M; Parrill AL; Quarles LD
J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
[TBL] [Abstract][Full Text] [Related]
12. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
[TBL] [Abstract][Full Text] [Related]
13. GPRC6A: Jack of all metabolism (or master of none).
Pi M; Nishimoto SK; Quarles LD
Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin and Sex Hormone Binding Globulin Compete on a Specific Binding Site of GPRC6A.
De Toni L; Guidolin D; De Filippis V; Tescari S; Strapazzon G; Santa Rocca M; Ferlin A; Plebani M; Foresta C
Endocrinology; 2016 Nov; 157(11):4473-4486. PubMed ID: 27673554
[TBL] [Abstract][Full Text] [Related]
15. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
Srinivasan S; Stephens C; Wilson E; Panchadsaram J; DeVoss K; Koistinen H; Stenman UH; Brook MN; Buckle AM; Klein RJ; Lilja H; Clements J; Batra J;
Clin Chem; 2019 Jan; 65(1):e1-e9. PubMed ID: 30538125
[TBL] [Abstract][Full Text] [Related]
17. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor.
Wellendorph P; Bräuner-Osborne H
Gene; 2004 Jun; 335():37-46. PubMed ID: 15194188
[TBL] [Abstract][Full Text] [Related]
19. Increased susceptibility to diet-induced obesity in GPRC6A receptor knockout mice.
Clemmensen C; Smajilovic S; Madsen AN; Klein AB; Holst B; Bräuner-Osborne H
J Endocrinol; 2013 May; 217(2):151-60. PubMed ID: 23428581
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor polymorphism-dependent variation in prostate-specific antigen concentrations of European men.
Bentmar Holgersson M; Giwercman A; ; Bjartell A; Wu FC; Huhtaniemi IT; O'Neill TW; Pendleton N; Vanderschueren D; Lean ME; Han TS; Finn JD; Kula K; Forti G; Casanueva FF; Bartfai G; Punab M; ; Lundberg Giwercman Y
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2048-56. PubMed ID: 25012998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
